University of Guadalajara   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Guadalajara Mexico (1925)

Organization Overview

First Clinical Trial
2003
NCT00561132
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Adolfo Daniel Rodriguez-Carrizalez | Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara | Doctorado en Farmacologia de la Universidad de Guadalajara | full time staff member at the Division of Pediatrics of the New Civil Hospital of Guadalajara | Head, Molecular Biology and Genomics Department, University of Guadalajara | Hospital Civil de Guadalajara | Hospitales Civiles de Guadalajara, Mexico | Institute of Experimental and Clinical Therapeutics | Institute of Experimental and Clinical Therapeutics (INTEC), CUCS | Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara | Instituto de terapeutica experimental y clínica | Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara | Instituto de terapéutica experimental y clínica (INTEC) | Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara | New Civil Hospital of Guadalajara | PhD. Teresa Arcelia Garcia Cobian | Ramón Óscar González-Ramella, Ph.D | Royal University of Guadalajara | Universidad de Guadalajara | Universidad De Guadalajara (UDG) | University Guadalajara | University of Guadalajara